The new method, reported in the latest issue of the journal Science, involves a certain protein called Tudor-SN and the gene-editing technology CRISPR-Cas9, Xinhua news agency reported.
On a closer look, the researchers found out how Tudor-SN is important in the "preparatory" phase of the cell cycle, the period when the cell gets ready to divide, according to the study.
"We know that Tudor-SN is more abundant in cancer cells than healthy ones, and our study suggests that targeting this protein could inhibit fast-growing cancer cells," Reyad A. Elbarbary, lead author of the study and research assistant professor in the Centre for RNA Biology and the department of Biochemistry and Biophysics at the University of Rochester School of Medicine and Dentistry, said in a statement.
The findings were made in kidney and cervical cancer cells in the laboratory and are a long way from being applied to people.
But the researchers said they could be the basis of a treatment option in the future.
(This story has not been edited by Social News XYZ staff and is auto-generated from a syndicated feed.)
About VDC
Doraiah Chowdary Vundavally is a Software engineer at VTech . He is the news editor of SocialNews.XYZ and Freelance writer-contributes Telugu and English Columns on Films, Politics, and Gossips. He is the primary contributor for South Cinema Section of SocialNews.XYZ. His mission is to help to develop SocialNews.XYZ into a News website that has no bias or judgement towards any.